Found 133 matching trials
A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01) PHASE3 This trial is a registrational Phase III, randomized, open-label, multicent...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer PHASE2 This is a prospective, single-center, single-arm study evaluating the combi...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial
Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma. PHASE2 Explore the efficacy and safety of mitoxantrone liposome combined with irin...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment PHASE1 This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Show More Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Learn More & Join Trial
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial PHASE2 This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Show More Location
Cancer Center of Guangzhou Medical University
Learn More & Join Trial
Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer PHASE2 This is a Multicenter, Non-randomized, Open Label, Multiple Dose, Multiple ...
Show More Location
Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma PHASE2 The purpose of this study is to assess objective tumor response in the sing...
Show More Location
Clinical Hospital Mostar
Learn More & Join Trial
Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma PHASE2 The current study is an investigator-initiated, single-arm phase 2 study th...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Study of Irinotecan Liposome in Advanced Pancreatic Cancer PHASE1 To determine the safety and tolerability of irinotecan liposome in combinat...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer. PHASE2 Phase II clinical study of irinotecan liposome (II)-based combination regim...
Show More Location
Chinese PLA General Hospital, Beijing,
Learn More & Join Trial